Raymond James Financial Services Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$27.5M Sell
52,801
-17,650
-25% -$9.18M 0.04% 430
2024
Q2
$38.2M Buy
70,451
+1,409
+2% +$763K 0.05% 321
2024
Q1
$35.8M Sell
69,042
-6,783
-9% -$3.52M 0.05% 334
2023
Q4
$35.8M Buy
75,825
+5,954
+9% +$2.81M 0.06% 310
2023
Q3
$30.4M Buy
69,871
+12,967
+23% +$5.65M 0.06% 319
2023
Q2
$25.3M Buy
56,904
+5,861
+11% +$2.6M 0.04% 389
2023
Q1
$23.5M Buy
51,043
+1,993
+4% +$916K 0.04% 394
2022
Q4
$25.2M Buy
49,050
+191
+0.4% +$98K 0.05% 363
2022
Q3
$22.2M Sell
48,859
-1,972
-4% -$896K 0.05% 364
2022
Q2
$24.5M Sell
50,831
-267
-0.5% -$129K 0.05% 351
2022
Q1
$25.1M Buy
51,098
+959
+2% +$471K 0.05% 377
2021
Q4
$23.2M Buy
50,139
+6,101
+14% +$2.83M 0.04% 400
2021
Q3
$16.4M Buy
44,038
+1,557
+4% +$581K 0.03% 500
2021
Q2
$16.2M Buy
42,481
+1,447
+4% +$553K 0.03% 506
2021
Q1
$14.7M Buy
41,034
+6,678
+19% +$2.4M 0.03% 481
2020
Q4
$11M Buy
34,356
+77
+0.2% +$24.7K 0.03% 521
2020
Q3
$9.21M Buy
34,279
+197
+0.6% +$52.9K 0.03% 531
2020
Q2
$8.97M Buy
34,082
+655
+2% +$172K 0.03% 492
2020
Q1
$7.59M Sell
33,427
-1,004
-3% -$228K 0.03% 438
2019
Q4
$10.4M Buy
34,431
+4,601
+15% +$1.39M 0.03% 494
2019
Q3
$7.16M Buy
29,830
+4,508
+18% +$1.08M 0.03% 566
2019
Q2
$7.15M Sell
25,322
-7,347
-22% -$2.07M 0.03% 548
2019
Q1
$9.38M Buy
32,669
+16,448
+101% +$4.72M 0.04% 444
2018
Q4
$4.26M Buy
16,221
+3,299
+26% +$867K 0.02% 593
2018
Q3
$3.54M Sell
12,922
-450
-3% -$123K 0.02% 784
2018
Q2
$3.18M Buy
13,372
+3,122
+30% +$743K 0.02% 791
2018
Q1
$2.25M Buy
10,250
+2,510
+32% +$551K 0.01% 876
2017
Q4
$1.74M Sell
7,740
-1,766
-19% -$397K 0.01% 979
2017
Q3
$1.81M Buy
9,506
+1,997
+27% +$379K 0.01% 968
2017
Q2
$1.41M Buy
7,509
+735
+11% +$138K 0.01% 1051
2017
Q1
$1.12M Buy
6,774
+978
+17% +$162K 0.01% 1108
2016
Q4
$833K Sell
5,796
-857
-13% -$123K 0.01% 1221
2016
Q3
$834K Sell
6,653
-197
-3% -$24.7K 0.01% 1192
2016
Q2
$900K Buy
6,850
+328
+5% +$43.1K 0.01% 1099
2016
Q1
$906K Buy
+6,522
New +$906K 0.01% 946